Joel P. Rousseau
Quebec, QC G1V0A6, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Prime Editing Mediated Generation and Correction of the mdx5cv Mutation Restores Dystrophin Expression in Myoblasts.
Journal: International journal of molecular sciences
Published: July 01, 2026
Successful In Vitro Modification of the Dmd Gene Using Prime Editing.
Journal: Cells
Published: February 11, 2026
In Vitro Correction of Point Mutations in the DYSF Gene Using Prime Editing.
Journal: International journal of molecular sciences
Published: April 28, 2025
Universal Prime Editing Therapeutic Strategy for RyR1-Related Myopathies: A Protective Mutation Rescues Leaky RyR1 Channel.
Journal: International journal of molecular sciences
Published: February 24, 2025
Molecular characterization of a new R1925X point mutation mouse model for dysferlinopathy.
Journal: Genes & diseases
Published: December 02, 2024
Emerging Perspectives on Prime Editor Delivery to the Brain.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: May 09, 2024
Successful Correction by Prime Editing of a Mutation in the RYR1 Gene Responsible for a Myopathy.
Journal: Cells
Published: November 23, 2023
Prime editing strategies to mediate exon skipping in DMD gene.
Journal: Frontiers in medicine
Published: December 20, 2022
Prime Editing Permits the Introduction of Specific Mutations in the Gene Responsible for Duchenne Muscular Dystrophy.
Journal: International journal of molecular sciences
Published: May 03, 2022
Prime editing optimized RTT permits the correction of the c.8713C>T mutation in DMD gene.
Journal: Molecular therapy. Nucleic acids
Published: February 22, 2022
Insertion of the Icelandic Mutation (A673T) by Prime Editing: A Potential Preventive Treatment for Familial and Sporadic Alzheimer's Disease.
Journal: The CRISPR journal
Published: February 08, 2022
Last Updated: 09/26/2026